The FDA sent the Danish drugmaker a complete response letter (CRL) declining to approve the drug, insulin icodec, saying that it needs more information on its manufacturing process, as well as ...

A recent study found that the homeostasis model assessment insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), and fasting glucose/insulin ratio (FGIR) were ...

insulin icodec, that we hope will reduce the disease burden even further. “Beyond this, we also aim to develop a glucose-sensitive insulin, which would only be activated in the body of the ...

LA CROSSE, Wis. (WEAU) - The La Crosse Fire Department responded to a structure fire Friday evening. The fire was on the 1400 block of Caledonia St. Upon arrival, crews found a home with heavy ...

Taking insulin can be daunting, especially administering it before or after you eat. Here are some tips to help you navigate insulin dosing at meal times. Insulin therapy plays a crucial role in ...

Compared with once-daily comparators, once-weekly icodec was associated with similar safety and efficacy outcomes regardless of race, ethnicity, or age. The hypoglycemic profile and efficacy of ...

The corps is a holistic structure. And let’s not even talk about the ‘attached’ units that break brigades into battalions and, let’s be honest, are not valued as much as the ‘main’ ones. It is time to ...

If the glucose concentration is <60 mg/dL, repeat the test and treat. Reduce the insulin infusion rate by 50% if tube feeding or TPN is stopped abruptly. Revert to hourly capillary blood glucose ...

People with LADA follow similar T1D practices with insulin, eating, exercise, and blood sugar management. Type 1.5 diabetes is commonly known as LADA, or latent autoimmune diabetes in adults.

Researchers are aiming to raise attention to the amount of waste generated with the use of diabetes devices, insulin and other treatment tools. Editor’s Note: This is part one of a two-part ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...